ALBANY, N.Y., Sept. 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 first quarter financial results on Monday, October 8, 2012, after the close of the U.S. financial markets.
